AD26.COV2.S
UNII JT2NS6183B

Substance Identification & Data

This profile provides standardized clinical and technical data for Ad26.cov2.s, uniquely identified by the FDA Unique Ingredient Identifier (UNII) JT2NS6183B.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
JT2NS6183B
CAS Registry Number
N/A
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
AD26.COV2.S
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C176055
National Cancer Institute reference terminology for clinical and research data.
Substance Type
structurallyDiverse
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
NCBI Taxonomy
28278
Unique numeric identifier used to specify biological species in the NCBI database.

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Ad26.cov2.s. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Systematic Nomenclature

AD26COVS1
RECOMBINANT, REPLICATION-INCOMPETENT ADENOVIRUS SEROTYPE 26 (AD26) VECTORED VACCINE COMPONENT ENCODING THE SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) SPIKE PROTEIN

Technical Codes

AD26.COV2.S
JNJ-78436735
VAC31518

External Clinical & Regulatory Resources

NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus